查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1937910

全球主動脈瓣置換裝置市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Aortic Valve Replacement Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計主動脈瓣置換裝置市場將從 2025 年的 84 億美元成長到 2034 年的 209 億美元，2026 年至 2034 年的複合年成長率為 10.66%。

受主動脈瓣狹窄盛行率上升和全球人口老化的推動，主動脈瓣置換裝置市場預計將顯著成長。隨著心血管疾病持續增加，高效能微創治療方法的需求日益成長。主動脈瓣置換術，特別是經導管主動脈瓣置換術術（TAVR），因其與傳統外科手術相比具有顯著的臨床獲益並縮短恢復時間而備受關注。

瓣膜設計和輸送系統的技術進步正在提高主動脈瓣置換術的安全性和有效性。生物瓣膜和創新材料的研發正在改善患者預後，並擴大可從這些手術中獲益的患者範圍。此外，以病人為中心的醫療模式日益受到重視，推動了對更耐用、性能更高的器械的需求，從而確保瓣膜置換術的長期成功。

此外，人們對心血管健康和早期診斷重要性的認知不斷提高，也推動了主動脈瓣置換裝置市場的成長。隨著醫療機構更加重視心臟疾病的主動管理，對先進診斷工具和治療方案的需求預計將會增加。遠端監測和遠端醫療等數位健康技術的整合也增強了患者參與度和後續護理，進一步促進了市場擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球主動脈瓣置換裝置市場：依產品分類

  • 市場分析、洞察與預測
  • 氣球膨脹類型
  • 自膨脹
  • 機械膨脹型
  • 主動脈瓣逆流

第5章：全球主動脈瓣置換裝置市場：依材料（瓣葉）分類

  • 市場分析、洞察與預測
  • 牛
  • 豬心包

第6章：全球主動脈瓣置換裝置市場：依框架材料分類

  • 市場分析、洞察與預測
  • 鈷鉻合金
  • 鎳鈦諾
  • 其他

第7章 全球主動脈瓣置換裝置市場：依最終用途分類

  • 市場分析、洞察與預測
  • 住院設施
  • 門診部

第8章 全球主動脈瓣置換裝置市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Boston Scientific Corporation
    • Artivion, Inc
    • LivaNova PLC
    • Abbott
    • Comp7
    • Medtronic
    • Edwards Lifesciences Corporation
    • CryolifeInc
    • JenavValve TechnologyInc
    • Micro Interventional Devices
    • Braile Biomedica
簡介目錄
Product Code: VMR11218099

The Aortic Valve Replacement Devices Market size is expected to reach USD 20.90 Billion in 2034 from USD 8.40 Billion (2025) growing at a CAGR of 10.66% during 2026-2034.

The aortic valve replacement devices market is set for substantial growth, driven by the increasing prevalence of aortic stenosis and the aging global population. As cardiovascular diseases continue to rise, the demand for effective and minimally invasive treatment options is becoming paramount. Aortic valve replacement procedures, particularly transcatheter aortic valve replacement (TAVR), are gaining traction due to their ability to provide significant clinical benefits with reduced recovery times compared to traditional surgical approaches.

Technological advancements in valve design and delivery systems are enhancing the safety and efficacy of aortic valve replacement procedures. The development of bioprosthetic valves and innovative materials is improving patient outcomes and expanding the eligibility criteria for patients who may benefit from these interventions. Additionally, the growing emphasis on patient-centered care is driving the demand for devices that offer improved durability and performance, ensuring long-term success in valve replacement.

Furthermore, the increasing awareness of cardiovascular health and the importance of early diagnosis are contributing to the growth of the aortic valve replacement devices market. As healthcare providers focus on proactive management of heart conditions, the demand for advanced diagnostic tools and treatment options is expected to rise. The integration of digital health technologies, such as remote monitoring and telemedicine, is also enhancing patient engagement and follow-up care, further supporting the market's expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Balloon-expandable
  • Self-expandable
  • Mechanically Expandable
  • Aortic Regurgitation

By Leaflet Material

  • Bovine Pericardium
  • Porcine Pericardium

By Frame Material

  • Cobalt-Chromium
  • Nitinol
  • Others

By End-Use

  • Inpatient Facilities
  • Outpatient Facilities

COMPANIES PROFILED

  • Boston Scientific Corporation, Artivion, Inc, LivaNova PLC, Abbott, Comp7, Medtronic, Edwards Lifesciences Corporation, Cryolife, Inc, JenavValve Technology, Inc, Micro Interventional Devices, Braile Biomedica

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Balloon-expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Self-expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Mechanically Expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Aortic Regurgitation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY LEAFLET MATERIAL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Leaflet Material
  • 5.2. Bovine Pericardium Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Porcine Pericardium Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY FRAME MATERIAL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Frame Material
  • 6.2. Cobalt-Chromium Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Nitinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Inpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Leaflet Material
    • 8.2.3 By Frame Material
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Leaflet Material
    • 8.3.3 By Frame Material
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Leaflet Material
    • 8.4.3 By Frame Material
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Leaflet Material
    • 8.5.3 By Frame Material
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Leaflet Material
    • 8.6.3 By Frame Material
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AORTIC VALVE REPLACEMENT DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Boston Scientific Corporation
    • 10.2.2 Artivion, Inc
    • 10.2.3 LivaNova PLC
    • 10.2.4 Abbott
    • 10.2.5 Comp7
    • 10.2.6 Medtronic
    • 10.2.7 Edwards Lifesciences Corporation
    • 10.2.8 CryolifeInc
    • 10.2.9 JenavValve TechnologyInc
    • 10.2.10 Micro Interventional Devices
    • 10.2.11 Braile Biomedica